Diabetes has been reported to impair vasodila tory responses in the peripheral vascular tissue. How ever, little is known about vasodilatory function in the diabetic brain. We therefore studied, in the N20-sedated, paralyzed, and artificially ventilated rat, the effects of chronic hyperglycemic diabetes on the cerebral blood flow (CBP) responses to 3 acutely imposed vasodilatory stimuli: hypoglycemia (HG) (plasma glucose = 1. 6-1. 9 !-Lmol ml-'), hypoxia (HX) (Pa02 = 35-38 mm Hg), or hypercarbia HC) (PaC02 = 75-78 mm Hg). In addition, we evaluated the somatosensory evoked potential (SSEP) and plasma catecholamine changes in rats exposed to acute glycemic reductions. Diabetes was induced via streptozotocin (STZ, 60 mg kg-' i.p.). All results in dia betic rats were compared to those obtained in age matched nondiabetic controls. The animals were studied at 6-8 weeks (HG experiments) or 4-6 months (HG, HX, and HC experiments) post-STZ. Values for CBP were obtained for the cortex (CX), subcortex (SC), brainstem (BS), and cerebellum (CE) employing radiolabeled micro spheres. Up to three CBP determinations were made in each animal. In 6-8 week diabetics vs. controls, CBP increased to a lesser value in the CX, SC, and BS (p < 0.05). Thus, in the diabetics, going from chronic hyper glycemia to acute hypoglycemia, CBP values (in ml 100 g-I min -I ± SD) increased (p < 0.05) from 89 ± 22 to 221 ± 57 in the CX, from 82 ± 21 to 160 ± 52 in the SC, and from 79 ± 34 to 237 ± 125 in the BS. In controls, going from normoglycemia to acute hypoglycemia, the CBP changes (p < 0.05) were 128 ± 27 to 350 ± 219 (CX), 117 ± 11 to 358 ± 206 (SC), and 130 ± 29 to 452 ± 25 4 (BS). CBP changes and absolute values in the CE were similar in the two groups. At 4-6 months post-STZ, a complete loss of the hypoglycemic CBP response was 667 found in the CX, SC, and CE.ln the BS, a CBP response to hypoglycemia was seen in the diabetic rats, with the CBP increasing from 114 ± 28 (hyperglycemia) to 270 ± 204 ml 100 g-I min -I (p < 0.05), compared to a change from 147 ± 36 (normoglycemia) to 455 ± 299 ml 100 g-1 min -1 (p < 0.05) in the control group. The hypoglycemic CBP values in these two groups were not statistically different. The hypoglycemic SSEP amplitudes were �50% lower in diabetic (6-8 week and 4-6 month) vs. nondiabetic rats (p < 0.05). Hypoglycemic plasma cate cholamine responses were significantly suppressed in di abetics compared to controls. Plasma epinephrine (E) and norepinephrine (NE) (in ng ml-I ± SD), in 6-8 week diabetics, increased from 0.23 ± 0.18 and 0.77 ± 0.29, respectively, in hyperglycemia, to 2.3 ± 1.0 and 1.3 ± 0.5 in normoglycemia (p < 0.05 for both E and NE), with no further changes in hypoglycemia. On the other hand, in controls, E and NE increased (p < 0.05) from 0.36 ± 0.09 and 0.84 ± 0.31 ng ml-1 (normoglycemia) to 8.5 ± 2.2 and 2.9 ± 1.0 ng ml-1 (hypoglycemia). No differences in the CBP increases accompanying hypoxia or hypercarbia were seen in diabetics vs. controls. These data suggest a selective suppression of the cerebral vasodilatory capac ity in the chronically hyperglycemic diabetic. The CBP results are discussed with respect to the possible contri butions of a sympathetic/cerebral �-adrenoceptor dys function. The SSEP findings indicate the importance of CBP increases during hypoglycemia in acting to attenuate the reduction in glucose supply and the severity of the functional disturbance.
Vascular pathology is a frequently observed com plication of diabetes mellitus. Although the majority of reports have focused on changes in peripheral vascular tissue, there are indications of an in creased incidence of cerebral vascular disease in diabetics (see Jarret et aI., 1982) . Furthermore, the diabetic patient appears to be at greater risk for stroke and stroke-related cerebral damage than the nondiabetic (Asplund et aI., 1980; Pulsinelli et aI., 1983) . . A cerebral microangiopathy has been re ported to be present in chronically diabetic humans (Reske-Nielsen et aI., 1965; Vandermot et aI., 1980) and rats. In diabetic hyperglycemic rats, morpho logical changes have been observed within 1 month of streptozotocin (STZ) treatment and have in cluded arteriolar smooth muscle abnormalities and arteriolar endothelial cell necrosis (Moore et aI., 1985; McCuskey and McCuskey, 1984) . However, there is little or no evidence correlating microvas cular histopathology with functional changes, par ticularly vascular reactivity.
Most of the work to date dealing with diabetes associated alterations in vascular function has in volved peripheral vascular tissue. A decrease in the vasodilatory capacity of peripheral vascular tissue is a frequently observed feature of the diabetic con dition. This includes a diminution of vascular endo thelium-dependent relaxations (Oyama et aI., 1986; Meraji et al., 1987; Tejada et al., 1989; Tesfemariam et aI., 1989) , a reduction in [3-adrenergic-mediated relaxation (Kamata et aI., 1989; Tejada et aI., 1989) , and an impairment of adenosine-induced vasodila tation (Hill et aI., 1985) .
The cerebral vasodilation, and accompanying in crease in cerebral blood flow (CBF), during condi tions like hypoglycemia, hypoxia, or hypercarbia is an important compensatory mechanism (for re views, see Siesjo, 1978; Busija and Heistad, 1984; Bryan, 1990) . In hypoglycemia, for example, an in creased CBF acts to improve glucose delivery and diminish the reliance of endogenous cerebral carbo hydrate stores (e.g., amino acids related to neuro transmission) and in this way may attenuate the ac companying functional abnormalities observed dur ing hypoglycemia (Lewis et al., 1974a,b; Butterworth et aI., 1982) . [3-Adrenergic stimulation has been shown to have a significant influence on the hyperemic response to hypoglycemia, but ap pears to play a limited role in the hypoxic or hyper carbic responses (see Busija and Heistad, 1984; Bryan, 1990) . Adenosine release has been shown to be a significant factor in the CBF increases accom panying hypoxia (Hoffman et aI., 1984; Morii et aI., 1987) and perhaps hypoglycemia (Winn et al., 1983) . Endothelium-dependent processes may also J Cereb Blood Flow Metab, Vol. 11. No.4, 1991 participate in hypoxia (Pearce et al., 1989) . Reports in the literature regarding diabetes-associated alter ations in cerebrovascular reactivity are very limited in number. Impaired CO2 responses have been ob served (Dandona et aI., 1978; Griffith et al., 1987) . However, there have been no reports indicating any changes in hypoglycemic or hypoxic CBF re sponses. In rats, there is some evidence of a reduc tion in the CBF increase following [3-adrenergic stimulation (Lass et aI., 1989 ) and a limited impair ment of endothelium-dependent vascular relaxation (Mayhan, 1989) . In particular, a diminished [3-adrenergic sensitivity might be predicted to result in a blunting of the CBF increase that normally ac companies hypoglycemia (see above).
The initial aims of the present study were to de termine in STZ-treated rats (a) whether a dimin ished cerebrovascular response to hypoglycemia exists and (b) if the hypoglycemic CBF response is blunted, and whether it is accompanied by any ce rebral functional manifestations. In that the above was found to be the case, we additionally sought to determine whether this diminished cerebrovascular reactivity was specific to hypoglycemia or reflected a more general reduction in the cerebral vasodila tory reserve (i.e., reduced CBF responses to hyp oxia or hypercarbia).
METHODS
The experimental protocol was approved by the Insti tutional Animal Care and Use Committee. Male Sprague Dawley rats (250-300 g initial weight) were employed. At the start of the experiments, the rats were anesthetized with halothane, paralyzed with curare (1 mg kg-I i.v.), and mechanically ventilated. During the surgical prepara tion, the rats were anesthetized with 0.7% halothane170% N20/30% 02' The following catheters were inserted: two femoral arterial, one femoral venous, and one left ven tricular (via the right carotid artery). In the hypoglycemic studies only, the skull was then exposed and three stain less steel screws were inserted (two to the left and one to the right of the sagittal suture in a frontoparietal config uration). Two needle electrodes were placed subcutane ously in the right whisker region for somatosensory evoked potential (SSEP) stimulation. All wound sites were then infiltrated with local anesthetic (bupivacaine), the halothane was switched off, and the rats were main tained on 70% N20/30% O2 (paralysis and artificial ven tilation). The PC02 was maintained at 35-40 mm Hg and the O2 at > 100 mm Hg. Rectal temperature was con trolled at 37°C. Arterial pressure was continuously re corded.
The two major experimental groups of this study were nondiabetic, age-matched controls (n = 18) and chroni cally hyperglycemic diabetics (CHDs, n = 20). The dia betes was induced with STZ given intraperitoneally (60 mg kg-I in pH 4.5 citrate buffer). The CHD rats were studied at 6--8 weeks (hypoglycemia studies only) or 4-6 months post-STZ. The body weights (±SD) measured at the time of study in the above groups were 320 ± 28 and 446 ± 58 g for the 6-8 week diabetics and their age matched controls, respectively, and 348 ± 55 and 541 ± 61 g for the 4-6 month diabetic rats and their age-matched controls, respectively. The rats were further divided into subgroups where one of the following acute conditions was imposed: hypoglycemia, hypoxia, or hypercarbia. Cerebral blood flow was measured using radiolabeled microspheres, according to procedures described by Hoffman et al. (1983) for microsphere injection into the left ventriCle. The following labels were employed: 57CO, 113Sn, and 85Sr. Four brain regions were evaluated: left cortex (CX), left subcortex (SC) (consists primarily of tissue from the striatum, thalamus, and hippocampus), brainstem (BS), and cerebellum (CE). The tissue weights were in the range of 0.3-0.5 g. This is sufficient to provide one with ?300-400 microspheres per sample. SSEPs were measured, in hypoglycemia experiments only, em ploying a Tracor 3000 evoked potential analyzer. The stimulus current was 3 rnA, with a duration of 0.1 ms and frequency of 5.5 Hz. A minimum of 250 consecutive re sponses were averaged.
In the hypoglycemia studies, the experimental design for the diabetic rats was to obtain a CBF measurement prior to insulin administration, under hyperglycemic con ditions (1 h posthalothane). Following intravenous injec tion of regular porcine insulin (40--60 U kg-I), CBF was again determined when plasma glucose reached the nor moglycemic range (5-8 !-Lmol ml-I) and when plasma glu cose subsequently fell to 1.5-2.0 !-Lmol ml-I (hypoglyce mia). The fall in plasma glucose to the normoglycemic range occurred within 30 min. An additional �60 min was needed to reach the hypoglycemic level. Evoked poten tials were evaluated at 15 min intervals, starting just prior to the first CBF measurement. In nondiabetic rats, a CBF determination was made, at 1 h posthalothane, prior to insulin (10-15 U kg-I) and during hypoglycemia when plasma glucose reached 1.5-2.0 !-Lmol ml-1 (�1-1.5 h later). As above, SSEP analyses were performed at 15 min intervals. In both groups, arterial samples were ob tained every 15 min for analysis of plasma glucocse. Ad ditional arterial samples were taken prior to and following the CBF measurements for analysis of blood gasses and pH. In the 6-8 week diabetic rats (and controls) only, � 1 ml blood samples were obtained following the CBF de terminations for subsequent analysis of plasma catechol amine concentrations. Whenever blood was obtained for catecholamine analysis, it was immediately replaced with an equivalent volume of heparinized blood taken from a donor rat. In other experiments, total blood loss amounted to <2 ml. Thus, no blood replacement was deemed necessary. For hypoxia, studies, rCBF was de termined with PaOz > 90 mm Hg (?1 h posthalothane) and after 15-20 min at a PaOz = 30--40 mm Hg (PaCOz and arterial pressure normal). For hypercarbia experi ments, rCBF was measured at PaCOz values of 35-40 mm Hg (?1 h posthalothane) and 70-80 mm Hg (15-20 min) (Pa02 and arterial pressure at initial normal values).
Arterial PCOz, paz, and pH were measured using an IL 1303 blood gas/pH analyzer. Plasma glucose analyses were performed employing a Beckman glucose analyzer
Plasma epinephrine and norepinephrine concentrations
were determined via a radioenzymatic assay (CateKit, Amersham). Statistical analyses were performed using a multi way analysis of variance (CBF, catecholamine, blood gas/pH, and arterial pressure data), a paired t test, based on differences (within-group SSEP data, with a Bonferroni correction applied for diabetic rats), or a non parametric Mann-Whitney U test (hypoglycemic SSEP data between groups). Statistical significance was taken at the p < 0.05 level.
RESULTS
The arterial P02 values in the hypoglycemia stud ies (not shown) were >90 mm Hg in all cases. No significant variations in peo2 were observed during any of the hypoglycemia experiments (Table 1) . A modest fall in MAP, from 116 to 101 mm Hg (p < 0. 05), was seen in the 6--8 week diabetic group when going from normoglycemia to hypoglycemia. In both the 6--8 week and 4-6 month diabetic rats, ar terial pH fell when going from chronic hyperglyce mia to normoglycemia (from 7.41 to 7.34 and from TABLE 1. Arterial blood variables during CBF evaluations in rats during chronic hyperglycemia (CH), normoglycemia (NG) , and hypoglycemia (HG)
37 ± 2 38 ± 2 37 ± 5 Age-matched control (n = 5) 37 ± 2 36 ± 4 MAP (mm Hg) 7.36 to 7.24, respectively; p < 0.05) with no further changes in hypoglycemia. Arterial pH fell from 7.34 to 7.25 in the 6--8 week controls and from 7.38 to 7.28 in the 4-6 month controls (p < 0.05 in both cases) when going from normoglycemia to hypogly cemia. However, the most important fact to note is that the respective normoglycemic and, particu larly, hypoglycemic plasma glucose values in dia betic vs. nondiabetic rats were virtually identical.
In the rats exposed to hypoxia ( In 6--8 week diabetic rats (upper portion of Fig.  I) , when going from hyperglycemia to normoglyce mia, regional cerebral blood flow (rCBF) increased significantly (p < 0.05) only in the cortex. The rCBF values in hypoglycemic 6--8 week diabetic rats were elevated from the initial hyperglycemic values in all regions (p < 0.05), but were signifi cantly higher (p < 0.05) than the diabetic, normo glycem ic flows in only the brainstem and cerebel lum. In nondiabetic rats, all regional hypoglycemic CBF values were increased from the normoglyce mic control levels (p < 0.05). When comparing 6--8 week diabetic and appropriate nondiabetic rats, rCBF values in the diabetic rats were lower, under hypoglycemic conditions, in the subcortex and brains tern (p < 0.05), averaging 48% of the nondi abetic value. In some agreement with previous re ports (Duckrow et aI., 1987; Harik and LaManna, 1988) , rCBF was lower (p < 0.05) in chronically hyperglycemic diabetic rats compared to normogly cemic nondiabetics in all of the regions studied (mean value = 68% of the nondiabetic value). In 4-6 month diabetic rats (lower portion of fig. I) , with the exception of the brainstem, there was an essentially complete loss of the cerebral hyperemic response to hypoglycemia, whereas this response was maintained in the appropriate controls. Re gional CBF values in diabetic rats were significantly lower (p < 0.05) in chronic hyperglycemia than in their normoglycemic, age-matched counterparts only in the cortex.
Plasma catecholamines
In diabetic rats, following acute glycemic normal ization, both epinephrine and norepinephrine in creased (p < 0.05) from the initial hyperglycemic values (Fig. 2 ) 10-and 1.6-fold, respectively. No further changes were observed in hypoglycemia. Substantial increases in plasma catecholamine con centrations from normoglycemic levels were seen in nondiabetic rats during hypoglycemia. Thus, epi nephrine increased 23-fold, while norepinephrine increased 3.5-fold (p < 0.05 in both cases). In dia betic rats, compared to nondiabetic rats, higher plasma epinephrine levels were found in normogly cemia (p < 0.05), whereas lower plasma epineph rine and norepinephrine concentrations were found in hypoglycemia (p < 0.05). However, initial cate cholamine concentrations in the diabetic vs. nondi abetic rats (i.e., hyperglycemia for the diabetics and normoglycemia for the nondiabetics) were not sig nificantly different.
Evoked potentials
To facilitate comparisons, we measured the peak to-peak amplitude difference (in f1 V) between the initial large positive deflection (P I) and the initial large negative deflection (N I) (see Fig. 3 for repre sentative patterns). As shown in Fig. 4 , the P1-N1 amplitudes varied considerably. Thus, in 6--8 week diabetic rats (upper portion of Fig. 4) , the amplitude increased �2-fold (p < 0.05) from the initial hyper glycemic value when plasma glucose was reduced to the normoglycemic range. This increase may be related in some way to the cerebral hypermetabo lism (see Pelligrino et aI., 1990a) and sympathoad renal activation (see Fig. 2 ) that occurs following acute glycemic normalization in chronically hyper glycemic diabetic rats. However, due to the lack of any direct or additional relevant evidence, no fur ther discussion of the possible causes for the in creased SSEP amplitude will be attempted at this time. Subsequently, in the present study, when
FIG. 1. Regional CBF values in diabetic and age-matched nondiabetic rats prior to and following acute glycemic reductions to the normoglylcemic range (chronically hypergly cemic diabetic rats) and to a hypoglycemic plasma glucose range of 1.5--2.0 ""mol ml-1 (both diabetic and nondiabetic rats plasma glucose fell to � 1.7-1.8 !-Lmol ml-I , the P I N I amplitude decreased to a level �25% of the ini tial value (p < 0.05) (see Fig. 4 , upper portion in set). In the age-matched nondiabetic rats, the hypo glycemic P I -N I amplitudes decreased from the normoglycemic values in every case (p < 0.05), achieving a level �52% of the initial value (upper portion inset, Fig. 4 ). Furthermore, amplitude re duction from the initial value was of a greater mag nitude in diabetic compared to nondiabetic rats ( Extending the diabetic duration to 4-6 months did not alter appreciably the magnitude of the hypoglycemia-induced amplitude depression relative to control (Fig. 4 , lower portion and inset). However, a reduced SSEP amplitude increase was observed in the 4-6 month diabetics, compared to the 6-8 week diabetics, following acute glycemic normalization. the initial value and are presented in Fig. 5 . For comparison, the rCBF data for 4-6 month diabetics and controls rendered hypoglycemic was treated in the same way and included in the figure. Unlike diabetic rats exposed to hypoglycemia, no suppres sion of the cerebral hyperemic response to hypoxia or hypercarbia was observed.
DISCUSSION
The results of this study demonstrated that the cerebral hyperemic response associated with hypo glycemia is blunted in the diabetic rat, with the mag- nitude of this effect becoming more pronounced as the diabetic duration is extended. On the other hand, the CBF increases that normally accompany acute hypoxia and hypercarbia in the rat are not altered, even after 4-6 months of chronic hypergly cemic diabetes. The absence of any measurable changes in CO2 reactivity in the diabetic rat con flicts with results from diabetic patients (Dandona et ai., 1978; Griffith et ai., 1987) . The possibility exists that the functional manifestations of a dia betic cerebrovascular pathology may be species de pendent. In support of this, cerebral autoregulatory function in diabetes has been reported to be im paired in humans (Bentsen et aI., 1975; Kastrup et aI., 1986) but normal in rats (Rubin and Bohlen, 1985) . Furthermore, in contrast to the present find ings, Neil et al. (1987) reported no difference in the CBF response to hypoglycemia (plasma glucose = 1-1. 3 !-Lmol ml-1) in diabetic vs. normal patients. It 
H ypo glycemia
should be stressed that the diabetics in this study were selected for their absence of signs of auto nomic neuropathy and angiopathy. It is conceivable that, in the presence of such diabetes-related pa thologies, the CBF responses in humans exposed to acute hypoglycemia may be affected (see below). This last point alludes to the fact that species dif ferences are not the only explanation for these con flicting findings. For example, chronic hyperglyce mia and the attendant glycosylation process have been suggested to be involved significantly in the development of diabetic angiopathies (see Brown lee et ai., 1988). Thus, differences in the severity and stability of hyperglycemia over extended peri ods of time could account for a measure of variabil ity in vascular pathology and reactivity.
The present findings have also indicated a signif icant reduction, in diabetic rats, in the hypoglyce mia-induced rise in circulating catecholamine levels Region CX SC BS one normally observes in nondiabetic rats (see Bryan et aI., 1987) . These results are similar to those reported by Patel (1983) , who reported a dim inution of the epinephrine response to hypoglyce mia in diabetic vs. nondiabetic rats. (3-Adrenergic stimulation appears to play an important role in the CBP response to hypoglycemia (see Bryan, 1990) . It is tempting, therefore, to ascribe the suppression of the hypoglycemic CBP response in the diabetic rats of the present study to the existence of a sym pathetic dysfunction in the diabetic animals. Along these same lines, a reduction in (3-adrenoceptor density in cerebral microvascular tissue obtained from diabetic rats has been reported (Magnoni et aI., 1984) . If the findings for microvessels (com posed primarily of capillary elements) are reflected in cerebral resistance vessels as well, then this may explain the finding by Lass et al. (1989) of an atten uation, in diabetic rats, of the CBP increase that normally accompanies administration of the (3-agonist isoproterenol. Of additional relevance is the recent finding that if one prevents the rise in circulating catecholamines (via adrenalectomy) dur ing sympathoadrenal activation, one can attenuate the accompanying CBP increase (Lacombe et aI., 1990) . The CBP response could be restored if epi nephrine were administered in these animals during the period of activation. Although the mechanism is unclear, this suggested a "permissive" role for plasma catecholamines in the cerebral hyperemia associated with sympathoadrenal activation. Whether such a mechanism contributes to the hy poglycemia-induced CBP increase awaits similar studies in adrenalectomized rats rendered hypogly cemic. Thus, if so, one might speculate that reduced No.4, 1991 CE circulating catecholamines as well as a diminished cerebral (3-adrenoceptor sensitivity could be acting together to produce the greatly attenuated CBP re sponse to hypoglycemia observed in the diabetic rats of the present study. Alterations in cerebral arteriolar endothelial and smooth muscle appearance have been observed as early as 1 month following STZ treatment in rats. Yet, previous studies have failed to produce any consistent pattern of functional abnormalities in di abetic rats (or mice) to correlate with the microvas cular histopathology. Thus, Mayhan (1989) found in chronically hyperglycermic rats, 3-4 months post STZ, an obtunded vasodilatory response of pial ar terioles to serotonin and adenosine diphosphate, but a normal response to nitroglycerin. This sug gested an impaired endothelial cell but a normal smooth muscle cell function. Rosenblum and Le vasseur (1984) reported that the pial arteriolar va soactive properties of both serotonin and the endo thelium-independent drug papaverine in diabetic mice were unaltered. This indicated both a func tionally normal microvascular smooth muscle and endothelium. Our findings of normal cerebral hy peremic responses to hypoxia and hypercarbia in 4-6 month diabetic rats also supports the presence of some cerebrovascular functional preservation at a time when one would expect a significant vascular histopathology. Thus, the present and earlier find ings demonstrate that, in spite of rather pronounced morphologic changes in cerebral resistance vessels, chronic hyperglycemic diabetes, at least in rats, is accompanied by specific rather than general reduc tions in cerebral vasodilatory capacity.
One other factor that merits some attention when discussing hypoglycemic CBF responses is changes in blood visocity. It has been shown that blood vis cosity and CBF are inversely related (for example, see Thomas et aI., 1977) . Acute hypoglyicemia, if anything, has been associated with an increased blood viscosity (Neil et aI., 1987) . Thus, viscosity changes probably cannot be invoked to explain the increased CBF we and others have observed during hypoglycemia in nondiabetic rats. It is also unlikely that viscosity effects were responsible for the dif ferences in the hypoglycemic CBF responses in di abetic versus nondiabetic rats for the following rea sons: Both chronic and acute hyperglycemia are of ten accompanied by limited increases in hematocrit and, by extension, blood viscosity (see Duckrow, 1990) . Acute reductions in plasma glucose from hy perglycemic levels might be predicted then to be associated with a fall in hematocrit and blood vis cosity, if these variables change at all, and a ten dency to increases CBF, not decrease it. Further more, the effects of hematocrit and viscosity changes on CBF in both diabetics and nondiabetics have been reported to be modest at best (Friedland and Grant, 1979; Duckrow, 1990) , adding additional support to our contention that viscosity effects were of little consequence in the present study. The blunted cerebrovascular reactivity to hypo glycemia in the diabetic rats was associated with a measurable cerebral functional deficit. This was ev idenced by the greater SSEP amplitude reduction in diabetic vs. nondiabetic rats at the same level of hypoglyicemia. Recent findings from our laboratory and by others (Duckrow, 1988; Harik and La Manna, 1988; Harik et aI., 1988; Pelligrino et aI., 1990a) permit one to eliminate a chronic hypergly cemia-induced reduction in the capacity of the blood-brain glucose transporter as an explanation for the hypoglycemic SSEP differences noted in the present study. Thus, present findings may provide some indication of the relative importance of a CBF increase during hypoglycemia in its effect on the functional status of the brain. As stated earlier (see also below), a CBF increase can attenuate the fall in the hypoglycemic blood-brain glucose influx rate, thus reducing the depletion of endogenous brain carbohydrates. It is of interest to note that the lev els of these substances are of sufficient magnitude to sustain a normal cerebral O2 consumption and energy status in "precoma" hypoglycemia (Nor berg and Siesjo, 1976) , but cannot prevent the ap pearance of neurologic abnormalities (Lewis et aI., 1974b; Butterworth et aI., 1982; Agardh and Rosen, 1983 ) (see also Figs. 3 and 4) . Reductions in the levels and turnover of neurotransmitters like gluta mate, "f-aminobutynic acid (GAB A), and acetyicho-line, beginning at a plasma glucose concentration =3 /-Lmol ml-I , have been reported (Lewis et aI., 1974a; Butterworth et aI., 1982; Ghajar et aI., 1985) . The possibility exists that the depletion of these substances may underlie some of the functional changes we and others have seen. In any case, there is little questoin that an adequate glucose supply to the brain is essential for the maintenance of a nor mal cerebral functional status. This assertion is ad ditionally supported by results obtained in rats ren dered chronically hypoglycemic. This condition is associated with an enhanced blood-brain glucose transport capacity (McCall et aI., 1986; Pelligrino et aI., I 990b ) . The resultant increased glucose trans port efficiency allows these animals to maintain rel atively normal SSEP (and EEG) patterns at levels of hypoglycemia that otherwise would have been accompanied by strikingly abnormal patterns in the above (Lewis et aI., 1974b; Agardh and Rosen, 1983; Pelligrino et aI., 1990b) .
In addition to an increased linear flow velocity, which would act to blunt the fall in cerebral capil lary glucose levels, one other possible hyperemia associated phenomenon that could attenuate the re duction in the blood-brain glucose influx rate is capillary recruitment. This would, if present, in crease the surface area for blood-brain glucose transport and, as a consequence, the number of available transporters. Although disputed as a pro cess occurring in the brain (Gobel et aI., 1989 (Gobel et aI., ,1990 , capillary recruitment has been reported to occur in the brain in association with hypoxic hyperemia (Francois-Dainville et aI., 1986) . It has also been suggested to be a principal factor in producing the glucose transport increases that accompany cere bral hypermetabolic states (Cremer et al., 1983 (Cremer et al., , 1988 . Chronic hyperglycemic diabetes does not, by itself, appear to alter capillary density or perfusion in rats (Kikano et aI., 1989) . However, the possibility that capillary recruitment may occur during acute hypoglycemia or that diabetes may im pair this process has not been investigated.
In conclusion, our results have shown that dia betic, chronically hyperglycemic rats exhibit a blunted cerebrovascular response to acutely in duced hypoglycemia, but normal responses to hyp oxia and hypercarbia. It was suggested that the de creased hypoglycemic CBF effect may be the result of a sympathetic/l3-adrenergic dysfunction. The greater hypoglycemic SSEP deficit observed in di abetic versus nondiabetic rats indicated that there is a central nervous system (CNS) functional manifes tation to the reduced CBF response. This provided an example of the fact that the CBF increase is an important compensatory mechanism in hypoglyce-mia and implies that the diabetic patient is at risk for a greater CNS functional impairment than the non diabetic should hypoglycemia ensue.
